CEO of Novartis, Vas Narasimhan, along with other colleagues, has issued a warning about Europeans' access to medicines.


Mr. Narasimhan told CNBC that the reality of the U.S. drug pricing policy, which offers the lowest prices, will become clearer over the next "18 months."
Mr. Trump has prioritized lowering drug prices for Americans and has long criticized what he calls "foreign countries exploiting innovations funded by the U.S."
View Original
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments